Caixin
Fosun and BioNTech to develop vaccine targeting omicron
Many drugmakers expect efficacy of existing jabs lower against new variant
Health Care & Pharma
Health Care
Olympus to reshape endoscope business in response to COVID
Company turns to disposable products and AI to ease burden on medical workers
Health Care
Thai BDMS bets on overseas telemedicine amid omicron threat
Hospital chain president says medical tourism to return to pre-COVID levels by 2023
Coronavirus
Japan expects to approve Merck's COVID pill in December
First oral medication expected to work on omicron variant
COVID vaccines
Moderna chief predicts existing vaccines will struggle with omicron
Stephane Bancel foresees 'material drop' in effectiveness of current jabs against new variant
COVID vaccines
Shionogi and Daiichi Sankyo join hunt for omicron vaccine
Japanese drugmakers prepare to modify shots under development
Coronavirus
No omicron lockdowns, but Biden says everyone needs booster
Stock market responds positively to president's assurance
Coronavirus: Free to read
Coronavirus: Week of Nov. 21 to Nov. 27, WTO postpones ministerial conference
U.S. to bar visitors from southern Africa; WHO names new COVID variant 'omicron'
Health Care
Fujifilm to spend $5bn to become global contract drugmaker
Opportunity seen in outsourcing trend similar to chip industry
Coronavirus: Free to read
Coronavirus: Week of Nov. 14 to Nov. 20, Hong Kong authorizes Sinovac vaccine for children aged 3-17
U.S. FDA authorizes boosters for all adults; Japan cabinet approves record stimulus
Pharmaceuticals
Eisai-Biogen Alzheimer's drug draws doubt from European regulators
Vote by European Medicines Agency panel deals setback to controversial $56,000-a-year treatment
Caixin
China searches for best tool kit to contain COVID-19
Country trying to strengthen lines of defense as pandemic persists
Economy
Vietnam bags greentech and vaccine investment from U.K., France
Standard Chartered, Sanofi and AstraZeneca scramble to gain foothold
Coronavirus
Avigan fails to prove COVID efficacy in U.S. trials, in blow to Fujifilm
Company will continue efforts in Japan, but path to American market looks closed
Pharmaceuticals
Japanese Nobel laureate settles with Ono Pharma over Opdivo suit
Settlement to go as donation to Kyoto University, where Tasuku Honjo is professor
Coronavirus
Japan prepares beds, booster shots in COVID lull before winter
PM Kishida secures 1.6m Merck antiviral pills to fight off possible 6th wave
COVID vaccines
Moderna, U.S. NIH in dispute over COVID vaccine patent rights
National institute head says its scientists deserve credit, takes case to court
Global Management Forum 2021
Takeda CEO sees workforce shifting to emerging countries
Christophe Weber calls Takeda 'a tech biopharmaceutical company'
Companies
GE to divide into 3 separate companies
Health care, energy and aviation will be focus of new businesses
Interview
Japan's Daiichi Sankyo to make mRNA vaccine pillar of business
CEO hints at using technology for applications other than COVID-19